Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort 2025-01-02
  2. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China 2024-12-23
  3. Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China 2022-01-09

Studies

3 studies carry this tag.

Date range

2022 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Alzheimer's research & therapy 1
  • Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's research & therapy 2025-01-02 Biomarkers

    Most investigations have previously focused on highly selected cohorts with established AD-endophenotypes (CSF biomarkers, autopsy report, PET etc.), while data on cohorts with clinical assessment are currently lacking, especially in non-European populations.

  2. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-23 Biomarkers

    The common and distinct risk factors across cognitive decline stages emphasize the need for tailored interventions.

  3. Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2022-01-09 Biomarkers

    Most genetic studies concerning risk genes in Alzheimer's disease (AD) are from Caucasian populations, whereas the data remain limited in the Chinese population.

All topic tags with their study counts